文献速递角膜与眼表疾病

糖皮质激素联合羊膜移植治疗严重边缘溃疡性角膜炎

[Treatment of severe marginal ulcerative keratitis by glucocorticoids combined with amniotic membrane transplantation].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2025-01-01

回顾性病例系列研究纳入2017年10月至2022年5月在山东第一医科大学附属眼科医院接受糖皮质激素联合羊膜移植治疗的严重边缘溃疡性角膜炎患者10例(10只眼),平均年龄61.3岁。术后随访1~18个月,所有患者术后视力均较术前显著提高,角膜溃疡在术后1~2周愈合,角膜基质水肿在1个月内完全消退。

要点

  • 10例(10只眼)严重边缘溃疡性角膜炎患者接受糖皮质激素联合羊膜移植治疗,术后视力均较术前显著提高。
  • 角膜溃疡在术后1~2周愈合,角膜荧光素染色阴性;角膜基质水肿在1个月内完全消退。
  • 表层大羊膜在术后7~10天自溶或脱落,内层羊膜紧贴溃疡面直至溃疡愈合,溃疡周围上皮细胞增生覆盖溃疡面。

核心结论

  • 采用糖皮质激素联合羊膜移植治疗的严重边缘溃疡性角膜炎患者在术后视力提升和角膜溃疡愈合方面表现较好的效果。

研究设计与样本

  • 回顾性病例系列研究,收集2017年10月至2022年5月于山东第一医科大学附属眼科医院接受糖皮质激素联合羊膜移植治疗的边缘溃疡性角膜炎患者10例(10只眼)。
  • 患者中男性6例、女性4例,平均年龄61.3岁。
  • 所有患者均接受角膜刮片、细菌培养、真菌培养及共聚焦显微镜检查,排除细菌、真菌及阿米巴感染。

主要发现

  • 术后随访1~18个月,所有患者术后视力均较术前显著提高。
  • 10例患者中有5例血免疫指标部分异常。
  • 角膜溃疡在术后1~2周愈合,角膜荧光素染色阴性;角膜基质水肿在1个月内完全消退。
  • 表层大羊膜在术后7~10天自溶或脱落,内层羊膜在溃疡愈合前一直紧贴溃疡面并随溃疡面缩小而缩小。
  • 溃疡周围上皮细胞增生并逐渐爬行至溃疡面小羊膜表面覆盖角膜溃疡面,溃疡深层纤维组织与羊膜融合共同填充溃疡组织缺损区。

关键数值与推荐

  • 对于前节相干光层析成像术检查显示内皮面有脓性渗出物附着的患者,术中通过前房冲洗分离取出内皮面的脓性渗出膜。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the clinical effectiveness of glucocorticoids combined with amniotic membrane transplantation in the treatment of severe marginal ulcerative keratitis. Methods: A retrospective case series study was conducted. Data from 10 patients (10 eyes) with marginal ulcerative keratitis who received glucocorticoid administration combined with amniotic membrane transplantation at the Eye Hospital of Shandong First Medical University from October 2017 to May 2022 were collected. There were 6 males and 4 females with an average age of 61.3 years. All patients underwent corneal scraping, bacterial culture, fungal culture, and confocal microscopy examination to exclude bacterial, fungal, and Acanthamoeba infections. The main indicators included visual acuity, intraocular pressure, corneal ulcer healing, and resolution of stromal edema. Results: The follow-up after surgery ranged from 1 to 18 months. Postoperative visual acuity in all patients was significantly improved compared to preoperative levels. Among the 10 patients, 5 had partial abnormalities in blood immune indicators. For patients with purulent exudates attaching to the endothelial surface as shown on anterior segment optical coherence tomography, anterior chamber irrigation was performed to remove the exudates during surgery. Corneal ulcers healed within 1 to 2 weeks postoperatively, with negative corneal fluorescein stainings. Stromal edema completely resolved within 1 month. The superficial large amniotic membrane autolyzed or fell off within 7 to 10 days, while the inner amniotic membrane remained closely attached to the ulcer surface until the ulcer healed, shrinking as the ulcer surface decreased. Epithelial cells around the ulcer proliferated and gradually crawled to the surface of the small amniotic membrane on the ulcer surface, covering the corneal ulcer surface. The deep fibrous tissue of the ulcer and the amniotic membrane fused, filling the defect area of the ulcer tissue together. Conclusion: Patients with severe marginal ulcerative keratitis treated by glucocorticoid administration combined with amniotic membrane transplantation achieved favorable visual acuity improvement and corneal ulcer healing. 目的: 探讨糖皮质激素联合羊膜移植治疗严重边缘溃疡性角膜炎的临床效果。 方法: 回顾性病例系列研究。收集2017年10月至2022年5月于山东第一医科大学附属眼科医院接受糖皮质激素联合羊膜移植治疗的边缘溃疡性角膜炎患者资料10例(10只眼),其中男性6例,女性4例;平均年龄61.3岁。所有患者均接受了角膜刮片、细菌培养、真菌培养及共聚焦显微镜检查,排除了细菌、真菌及阿米巴感染。主要指标包括视力、眼压、角膜溃疡愈合情况和基质水肿消退情况。 结果: 术后随访1~18个月。患者术后视力均较术前显著提高。10例患者中有5例血免疫指标部分异常。对于内皮面有脓性渗出物附着的患者,术前前节相干光层析成像术检查显示内皮面有脓性渗出物,术中通过前房冲洗分离取出内皮面的脓性渗出膜。术后1~2周角膜溃疡愈合,角膜荧光素染色阴性。1个月角膜基质水肿完全消退。7~10 d表层大羊膜均自溶或脱落,内层羊膜在溃疡面愈合前一直紧贴溃疡面,随角膜溃疡面缩小而缩小,溃疡周围上皮细胞增生,逐渐爬行至溃疡面的小羊膜表面,覆盖角膜溃疡面,溃疡深层的纤维组织和羊膜融合,共同填充溃疡组织缺损区。 结论: 采用糖皮质激素联合羊膜移植治疗的严重边缘溃疡性角膜炎患者,在术后视力提升和角膜溃疡愈合方面表现较好的效果。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jia YN, Wang JT, Wang X, et al. [Treatment of severe marginal ulcerative keratitis by glucocorticoids combined with amniotic membrane transplantation]. Zhonghua Yan Ke Za Zhi. 2025. PMID: 39939007. doi:10.3760/cma.j.cn112142-20240710-00297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。